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Summary
Studies in our laboratories have indicated that pancreatic cancer
originates not only from pancreatic ductal/ductular cells but also
from within the Langerhans' islets, probably from reserve
(precursor, stem) cells. To identify, enrich and characterize these
cells, we established a long-term hamster islet culture and studied
their growth, differentiation and response to the pancreatic
carcinogen, N-nitrosobis(2-oxopropyl)amine (BOP). One group of
cultured islets was treated in vitro with BOP (KL5B group) and the
other group of islets served as an untreated control (KL5N group).
During the early culture days, in both groups all cultured islets
showed a progressive loss of endocrine cells and replacement by
ductular, acinar and intermediary cells. However, all these cells
disappeared after 35 days in culture and gave room to
undifferentiated cells, which we believe represent stem cells. No
differences were found between KL5N and KL5B cells with regard
to cell growth and differentiation until day 35, when the growth of
the KL5B cells accelerated and the cells underwent increasing
pleomorphism and atypia. At day 133, KL5B cells but not KL5N
cells showed colony formation in soft agar and formed invasive,
poorly differentiated adenocarcinomas of the ductal type when
transplanted into hamsters. All of these tumors showed mutation of
the K-ras gene and extensive chromosomal damage. We concluded
that like ductal/ductular cells, certain cell populations within islets
are responsive to the carcinogenic effect of BOP. We could not
ascertain whether these cells present a preexisting (stem, reserve)
cell population within the islets or transdifferentiated islet cells.
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Introduction
The histogenesis of pancreatic cancer is obscure. The
opinion about the tumor precursor cells varies and includes
ductal cells, ductular cell and acinar cells. Studies in the
hamster pancreatic cancer model, which in many aspects
resembles human pancreatic cancer [ 1 -7], have indicated that
tumors arise from ductal and ductular cells, as well as within
islets [8]. In fact, the earliest alteration during cancer
development is the formation of intrainsular ductular
structures that give rise either to lesions compatible with the
human microcystic adenomas, or malignant glandular
structures that destroy the islets and invade the surrounding
tissue even when they are microscopic in size. On the
contrary, ductal lesions develop much later, and remain
within the ductal boundary for a long time before they
become invasive. This pattern is consistent with intraductal
tumors in humans. The greater malignancy of intrainsular
cancers is thought to be due to the exposure of the evolving
tumor cells to a high concentration of growth factors within
the islet environment, and the lack of a connective tissue
barrier around the islets. Although our studies have
substantiated the role of islets in pancreatic carcinogenesis
[9,10], the identity of the tumor precursor cells, which we
believe represent stem (reserve) cells remains obscure. To
identify, characterize and enrich these stem cells, and test
their response to the pancreatic carcinogen, N-nitrosobis(2-
oxopropyl)amine (BOP), we established a long-term hamster
islet culture.
Material and methods
Islet isolation
Pancreatic islets of female hamsters were isolated and purified as described
[II].
Islet culture
Isolated islets were cultured in M3:5 medium (InCell™, San Antonio, TX)
and were kept on a rocker for 14 days to prevent their attachment to the
bottom of the dish and to remove fibroblasts. The islets were divided into
two groups, KL5N (200 islets, no BOP treatment) and KL5B (250 islets
treated with BOP). The floating islets were handpicked every day, counted
and put into a new petri dish containing fresh medium to separate them
from the fibroblasts that attached to the bottom of the flask. On day IS
from the initial isolation, when no fibroblast contamination was evident
anymore, islets from each group were removed from the rocker, transferred
into six-well tissue culture plates and allowed to attach. They were
continuously cultured without shaking and subcultured in M3:5 when
subconfluent. Portions of the cells were harvested for soft agar assays, K-
ras mutation analysis, histology/immunohistochemistry, or electron
microscopy.
BOP treatment
KL5B Islets were treated with 0.25mM BOP from the first day of islet
culture. A pilot study had shown that this concentration had no toxic effect
and was well tolerated by the islet cells. The media were changed every
day for the first 14 days and three times per week thereafter. BOP was
added to the fresh medium for the BOP treated group and discontinued
after day 133.
Histochemical and immunocytochemical examinations
All examinations, including the multilabeling technique, were performed
as previously described [12]. Antibodies used in this experiment are
reported in our earlier study [11,13].
Electron microscopy
The subcellular patterns of the cells at different culture days were
examined as reported earlier [14].
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Anchorage-independent growth
assay was performed as reported earlier [15]. Formation of colonies was
checked once a week and the assay discarded after 45 days.
Transplantation experiment
About 1 million KL5B or KL5N cells at day 133 were transplanted into the
subcutaneous tissue, the submandibular gland, or into the pancreas of
recipient hamsters (three hamsters persite), as reported [16]. Subcutaneous
masses, lesions in the submandibular gland and pancreas were removed at
autopsy, and all organs were examined grossly for metastases. The regional
lymph nodes of these hamsters and the pancreas of three age-matched
control hamsters were removed, fixed in 10% buffered formalin, and
processed for histology by conventional methods.
Examination of the K-ras mutation
The mutation of K-ras was examined by RT-PCR and direct sequencing,
according to a previously described method [15].
Cytogenetic analysis
The karyotype of KL5N and KL5B at days 133 and 238 was performed as
reported [15]. Fifty-one KL5B and forty-two KL5N cells were examined
at each sample.
Results
Islet culture
The growth patterns of both KL5N and KL5B islets were
similar. Islets retained their original size and spherical shape,
and showed the same distribution of individual islet cells as
in the native pancreas. Examination of 500 freshly isolated
cells by immunohistochemistry (using antibodies against
islet hormones and hamster ductal specific pancytokeratin)
and electron microscopy did not show any exocrine cells
attached to the islets. Beginning at day seven, P-cells
showed necrosis, their number decreased rapidly and were
replaced by an increasing number of ductular structures.
These ductular structures all appeared in the center of the
islets (Fig. 1). Initially they formed minute conducts which
could be detected electron microscopically (Figs. 2, 3). The
ductules, composed of cells of various sizes, showed regular
microvillae with junctional complexes between each other
(Fig. 3) and were surrounded by endocrine cells. The a- and
8-cells, identified by the respective antibodies, occupied the
peripheral islet region and survived about one to two weeks
longer than P-cells. At day 14, in the KL5N and KL5B
culture, the number of floating islets was reduced by 30%.
At day 21, after one week off the rocker, single cells or
small groups of acinar cells, and a few intermediary cells
were found between the ductular and endocrine cells. The
latter cells were still immunoreactive to anti-glucagon and
anti-somatostatin but not to anti-insulin anymore. At day 28,
the core of the islets was consistent of amorphous material
that contained nuclear shadows (Fig. 4). The surface of the
core was covered by cuboidal or cylindrical epithelial cells
forming a monolayer or multilayers (Fig. 4). These cells
expressed pancytokeratin but not endocrine islet cell
markers. At day 35, both KL5N and KL5B presented an
undifferentiated cell type with large eosinophilic cytoplasm
and poor in cell organelles. A few small cells with
hyperchromatic nuclei were scattered between the large
cells.
At day 56, the growth rate of KL5B cells accelerated and
showed a doubling time of 36 hours, compared to 48 hours
in KL5N cells. Although KL5N cells retained their
monomorphic phenotype (Fig. 5a), the KL5B group was
composed of a mixture of normal looking cells and of small
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Figure 1: An islet in culture for seven days. Two small ductular structures
(d) surrounded by endocrine cells are seen in the center of the islet. A few
large epithelial cells (arrow) were scattered between the endocrine cells.
H&E x 40.
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Figure 2: infrastructure of a similar ductule as in Fig. 1 showing a portion
of ductular cells (D) between the lumen (L) and endocrine cells with
granules, and Golgi stacks (G) around the nucleus (N). x 3000.
Figure 3: A minute ductule within an islet at day seven. Ductular structures
formed by small epithelial cells are surrounded by endocrine islet cells.
Portion of a ductular cell extends between two endocrine cells (arrows).
X3000.
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Figure 4: An islet at day 28. The islet core (C) presents amorphous meshy
material with nuclear shadows. Accumulation of cuboidal or cylindric
epithelial cells on the surface of the core. H&E x 25.
cells with hyperchromatic nuclei (Fig. 5b). The number of
the small cells increased gradually and at day 133 the culture
was composed entirely of small cells with pleomorphic and
hyperchromatic nuclei, and scanty eosinophilic cytoplasm
(Fig. 5c).
Anchorage-independent growth
At day 133, in contrary to KL5N cells, KL5B cells showed
for the first time anchorage independent growth in soft agar
and could be maintained in RPMI-1640 culture medium
supplemented with 10% fetal bovine serum.
Activation of K-ras oncogene
The mutation of the K-ras was found only in KL5B cells at
day 133 and later. The mutation was in codon 12
(GGT-GAT), as found in primary pancreatic cancers [1], in
the cell lines derived from them, and in BOP-induced tumors
arising from islets in vivo [17].
In vivo growth patterns of KLSB cells
One million KL5B cells injected into the subcutaneous tissue
of all 9 hamsters grew up to 20-mm nodules within two
weeks. All of these tumors were invasive, and depending on
the site of tumor cell inoculation, they had invaded the
abdominal wall, the peritoneum, pancreas, or the
submandibular glands. No metastases were detected.
Histologically, tumors of all three sites were anaplastic with
massive necrosis and hemorrhage (Fig.6).
Cytogenetic analysis
Cytogenetic analysis of KL5N at day 133 showed a normal
hamster chromosome complement [13]. However, forty-five
KL5B cells presented an abnormal clone characterized by a
missing Y, monosomy 7 and 11, one copy of two markers,
and two copies of another marker. Six cells were a tetraploid
version of this clone.
Immunohistochemical findings
Examination of KL5N and KL5B cells at day 133 showed
that expression of laminin, EGFR and its ligand TGF-cc (Fig
7) was much higher in KL5B cells than in KL5N cells
(Table 1). Both KL5N and KL5B cells were about the same
reactive to antibodies against pancytokeratin, cytokeratins
14,18, carbonic anhydrase, vimentin, tomato lectin, PHA-L,
and oc-1-antitrypsin. Immunohistochemical findings in
tumors of different transplantation sites are summarized in
Table 2. We found a higher expression of EGFR and TGF-a
in the tumors
grown in the SMG and pancreas compared to the
subcutaneous grown tissue.
Discussion
Genetic changes found in hyperplastic and dysplastic lesions
of ducts in human individuals without pancreatic cancer
[18], as well as in carcinoma in situ or pancreatic cancer,
imply that ductal cells are the tumor progenitor cells. Also,
in the hamster pancreatic cancer model, tumors derive from
ducts and ductules [19]. And the malignant transformation
of hamster ductal cells treated in vitro with BOP clearly
points to the susceptibility of hamster ductal cells to
malignancy. However, in the hamster treated with BOP,
most cancers develop within islets [20] and several studies
have indicated that the presence of intact islet cells is
prerequisite for pancreatic cancer induction by BOP [20,21].
Destruction of islets by diabetogenic compounds inhibits or
Figure 5: a) KL5N cells after 56 days in culture. Undifferentiated uniform
monomorphic cells with large cytoplasm and regular nuclei with tendency
to adhere to each other. H&E x210. b) KJL5B cells at day 56. Pleomorphic
cell population with small and large cells. H&E x210. c) KL5B cells at day
133. Small, pleomorphic cells with hyperchromatic nuclei and small
cytoplasms. At this stage, the cells grew in soft agar and could be
maintained in RPMI-1640.
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Figure 6: Histological pattern of KL5B cells obtained from a subcutaneous
tumor grown in a hamster. Anaplastic tumor is composed of pleomorphic
cells forming occasionally minute glandular structures. Large necrotic and
hemorrhagic areas were present in the center of the tumor. H&E x210.
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Figure 7: a) KL5N cells at passage 32 express EGFR. Positive staining was
found in about 10%. b) Membrane staining of the same antibody in KL5B
cells. About 80% of the cells expressed EGFR. ABC method x210.
prevents pancreatic carcinogenesis [21-23], whereas
stimulation of islet neogenesis promotes it [24].
Consequently, it appears that a certain cell population within
the ducal tree and within islets, most probably the stem cells,
presents the tumor progenitor cells. However, it was not
clear whether tumors developing within islets, derive from
undifferentiated precursor (stem cells) or from
transdifferentiated islet cells. To answer these questions, we
established a hamster islet culture and treated the islet cells
with BOP in vitro. The results confirmed our in vivo
observation that, like ductal cells, some cells within islets
have the potency to give rise to an exocrine cell tumor. The
origin of these cells from exocrine cells attached to the islets
could be excluded because in over 500 islets that were
purified by our technique and examined in a pilot study,
immunohistochemically and electron microscopically did not
reveal any exocrine cell contamination. Moreover, contrary
to freshly isolated islets, all islets in culture showed
formation of many ductules as early as 7 days in culture and
the appearance of these ductular structures coincided with
the necrosis and disappearance of the p-cells. Our results are
in line with observations by other investigators [25-27], and
suggest, that human islets in culture differentiate into
ductular cells. Strikingly, in our study intermediary and
acinar cells were also developed within cultured islets but
were not found in the primary islets, indicating a pluripotent
differentiation capability of islet cells. Whether these
exocrine cells derive from preexisting precursor (stem) cells
or from transdifferentiated islet cells is debatable.
Nevertheless, in culture, BOP transformed hamster islets.
These cells injected into the hamster formed a ductal-type
adenocarcinoma. Compared to the well-differentiated
TAKA-1-BOP tumor, which was induced by injection of
BOP treated hamster ductal cells in vitro [15], the KL5B
tumor was anaplastic and highly invasive. Contrary to
TAKA-1-BOP cells, KL5B cells showed K-ras mutation
and more extensive chromosomal alterations. In particular,
the missing Y chromosome is noteworthy, because ILA
tumor cells [28], which were induced by BOP in a hamster
submandibular gland bearing a homologous islet transplant,
also showed this abnormality. Also noteworthy is that the
missing Y chromosome has been found to be one of the
most consistent abnormalities of human pancreatic cancer
[29]. Whether this abnormality is associated with the
malignancy of specific pancreatic cells remains to be seen.
The invasive nature of the KL5B- and ILA tumor cells
could be related to the exposure of evolving tumor cells
within islets to a high concentration of growth factors.
Moreover, simultaneous expression of vimentin and
cytokeratines in KL5B cells, also found in aggressive
human breast cancer [30] seems to be associated with
invasive behavior. The same evidence seems to apply to the
lack of blood group A antigen expression. We have shown
that well-differentiated, BOP-induced tumors and the slow
growing PC-1 cell line derived from a primary BOP-induced
cancer [14], consistently express blood group A antigen
[31]; whereas, the poorly differentiated, fast-growing PC-1.0
Table 1: Immunohistochemical reactivity of antibodies to normal hamster pancreas, KL5N and KL5B cells (day 224)
Antibody Normal pancreas KL5N KL5B
Pancytokeratin
Cytokeratin 14
Cytokeratin 18
Carbonic anhydrase II
Laminin
Vimentin
Tomato lectin
PHA-L
TGF-a
EGFR
a-1-Antitrypsin
"•"(100)
++'(100)
++'(100)
+6(20)
+ "(100)
+++'(30)
++•(20)
+++"(5)
+ (20)
+++"(50)
"(70),+(20)
+"•"(100)
+++' (20)
++•(10)
+++'(10)
+•(20)
++"(100)
"'(100)
+"(100)
+"(10) + +"(80)
++'••''(100)
(%) percentage of stained cells; -, No staining; +, weak staining; ++, moderate staining; +++, strong staining
°, diffuse cytoplasmic;b, acinar, islet-and ductal cells staining; *, staining of ductal cells only;c, staining of smooth muscles only;
d
, cell membrane staining;c, diffuse cytoplasmic staining of zymogen granules and of islet cells, luminal staining of ductal cells;
f
, diffuse cytoplasmic staining of zymogen granules and islet cells;s, staining of glucagon cells only.
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Table 2: Immunohistochemical reactivity of antibodies to KLSB cells (day 224) injected subcutaneously, and into the submandibular gland (SMG) or
pancreas
Antibody Subcutaneously SMG Pancreas
Pancytokeratin
Cytokeratin 14
Cytokeratin 18
Carbonic anhydrase
Laminin
Vimentjn
Tomato lectin
PHA-L
EGFR
TGF-o
q-1-Antitrypsin
+'(10)
+*(5)
+•(10)
.
+ '(100)
+ to+++c(100)
K+tO+++"(100)
+ '(100)
+ '(30)
+ •(40)
+ '(70)
+ 10++" (10)
+"(5)
+"(10)
+•(4)
+"(100)
+++c(100)
+ to+++b(l00)
+++e (100)
+'(60)
+•(65)
++" (80)
+ to ++' (20)
+"(2)
+"(10)
+•(5)
+ to+++"•" (100)
+ to ++ c (80)
+ to++"(100)
+ +•(80)
+ +' (80)
+ '(60)
(%) percentage of cells stained; -, No staining;
tumor cells, strong staining of blood vessels;"
+, weak staining; ++, moderate staining; +++, strong staining. *, diffuse cytoplasmic;b, weak staining of
, granular cytoplasmic staining;d, cell membrane and vascular staining;e, cell membrane staining
cells, derived from a subcutaneous transplant of a primary
hamster pancreatic cancer, do not. This finding may indicate
that the blood group antigen represents a differentiation
marker. However, contrary to PC-1.0 cells, which assume
blood group A antigen expression when transplanted into
hamsters [16], KL5B cells failed to produce this antigen in
vivo. This may be related to the extensive genetic changes in
KL5B cells. On the other hand, the expression of a-1-
antitrypsin, in both KL5N and KL5B cells but not in any
adult hamster pancreatic cells, may support the origin of
these cells from a primitive precursor cell. This acute-phase
reactant protein has been found in human pancreatic tumors
assumed to derive from stem cells, including solid cystic
(papillary) tumor [32] and pancreatoblastoma [33]. Hence,
this protein, as well as vimentin, not present in pancreatic
parenchymal cells, appears also to represent a marker for
hamster pancreatic stem cells [34]. Although it appears that
tumors originating from ductal cells or from within islets,
have different biological appearance, confirmatory studies
are required.
The malignant alteration of islets by BOP in culture
unequivocally points to the ability of islet cells to metabolize
BOP. Consequently, it appears that both, hamster ductal
cells [15], and islets can be transformed by BOP and both
have the necessary enzymes to metabolize BOP.
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